The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 346:614-616 February 21, 2002 Number 8
NextNext

Genes, Microbes, and T Cells — New Therapeutic Targets in Crohn's Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel disease, affect up to 1 million people in the United States. These related but distinct diseases are complex disorders with immunologic, environmental, and genetic components, each of which is the subject of intense investigation. In 1996 a gene conferring susceptibility to Crohn's disease was identified on chromosome 16 in families with multiple affected members. Now two groups, working independently and using different strategies, have identified the relevant gene at that locus.1,2

The gene is named NOD2, and is similar to the R factor genes of plants that confer resistance to . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.